Table 5. Baseline characteristics of patients with left ventricular assist device with or without ICH after LVAD implantation (without ICH vs. LVAD with ICH).
| Demographics | LVAD without ICH (weighted N=16,935) | LVAD with ICH (weighted N=387) | P values |
|---|---|---|---|
| Age category (years) | 0.06 | ||
| 18–35 | 1,567 [9] | 71 [18] | |
| 36–50 | 3,134 [19] | 73 [19] | |
| 51–65 | 7,862 [46] | 178 [46] | |
| >65 | 4,372 [26] | 65 [17] | |
| Femalea | 4,224 [25] | 104 [27] | 0.7 |
| Race | 0.9 | ||
| White | 9,256 [55] | 204 [53] | |
| Black | 3,392 [20] | 95 [24] | |
| Hispanic | 866 [5] | 19 [5] | |
| Asian/Pacific Islander | 200 [1] | 5 [1] | |
| Others/missing | 3,221 [19] | 64 [16] | |
| LVAD in previous hospitalization | 10,625 [63] | 248 [64] | 0.8 |
| Waiting for heart transplant | 1,784 [11] | 34 [9] | 0.6 |
| Charlson Comorbidity Indexb | |||
| 0–1 | 3,716 [22] | 15 [4] | |
| 2 | 5,479 [32] | 95 [25] | |
| 3 | 4,607 [27] | 138 [35] | |
| 4+ | 3,133 [19] | 139 [36] | <0.0001 |
| Abnormal coagulation profile | 2,265 [13] | 70 [18] | 0.2 |
| HTN | 7,864 [46] | 120 [31] | 0.005 |
| MI | 3,841 [23] | 82 [21] | 0.8 |
| Valvular disease | 3,087 [18] | 25 [6] | 0.01 |
| PVD | 1,051 [6] | 19 [5] | 0.6 |
| Chronic lung disease | 6,126 [36] | 97 [25] | 0.1 |
| DM | 5,449 [32] | 79 [20] | 0.05 |
| Liver disease | 1,324 [8] | 60 [16] | 0.05 |
| Renal disease | 5,791 [34] | 84 [22] | 0.06 |
| Year | 0.7 | ||
| 2007 | 910 [5] | 36 [9] | |
| 2008 | 1,906 [11] | 34 [9] | |
| 2009 | 3,747 [22] | 68 [18] | |
| 2010 | 4,959 [29] | 122 [31] | |
| 2011 | 5,413 [32] | 127 [33] |
a, 4 observations with missing values for sex; b, can range from 0 to 17. ICH, intracranial hemorrhage; LVAD, left ventricular assist device; HTN, hypertension; AF, atrial fibrillation; PVD, peripheral vascular disease; DM, diabetes mellitus.